NICE backs Roche's Kadcyla for HER2-positive early breast cancer

11th May 2020 Uncategorised 0

Around 800 people will be eligible for treatment with Kadcyla

More: NICE backs Roche's Kadcyla for HER2-positive early breast cancer
Source: News